Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 S pseudogene 2 (UBE2SP2)

Target: UBE2SP2
Molecular classification: Other (Pseudogene)

Overview

Ubiquitin conjugating enzyme E2 S pseudogene 2 (UBE2SP2) is a pseudogene related to the functional ubiquitin conjugating enzyme E2 S (UBE2S), which is involved in the post-translational modification of proteins via ubiquitination. Unlike UBE2S, which has notable roles in cell cycle regulation, mitosis, and cancer biology[5][2], UBE2SP2 is classified as a pseudogene and does not encode a functional protein. There are no current data supporting its role as a therapeutic target, nor any association with active biological functions, disease phenotype, or drug interactions.

Other names: UBE2S pseudogene 2UBE2S-P2UBE2SP2

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 S pseudogene 2 (UBE2SP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 S pseudogene 2 (UBE2SP2).

Explore the full profile